Saturday, February 21, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

The Politics of Fentanyl

Watch the election spin

Jay K Joshi by Jay K Joshi
March 26, 2024
in Politics & Law
0
The Politics of Fentanyl

Ana Pieters

The 2024 US presidential election is undoubtedly significant, and to truly grasp its implications, it is crucial to delve into the complex issue of fentanyl and its impact on American society. Over the past years, the nation has faced an alarming surge in overdose deaths caused by the synthetic opioid, leaving many communities and families devastated. Fentanyl, which was once only used within hospital settings, has now transformed into a widely available street drug, manufactured by criminal organizations, predominantly in Mexico.

The production process often involves utilizing cheap chemicals that are typically sourced from China. What makes fentanyl particularly dangerous is its frequent presence as a hidden ingredient in various illicit drugs. Consequently, unsuspecting users unknowingly consume this lethal substance, triggering fatal consequences, which in aggregate we see most apparently in the rising opioid overdose rates.

This opioid crisis has left an indelible mark on the population, fostering an atmosphere of fear, despair, and urgency. As the 2024 presidential election approaches, candidates will undoubtedly address the gravity of this issue, offering their own strategies and solutions to combat the fentanyl epidemic.

Ultimately, however, rather than safeguard the well-being of the American people, candidates will offer a spin on the fentanyl crisis that will serve their political ambitions. This is a shame, because what is good for their political careers is anything but that for the American public.
One of the most despicable tactics used by these candidates is fear-mongering. They prey on the understandable fears and concerns of the public, using exaggerated rhetoric and misinformation to manipulate their emotions. They paint a picture of chaos and danger, promising quick and easy solutions that they know will never materialize.

These candidates exploit the vulnerability of those affected by the fentanyl crisis. They offer false hope and empty promises, knowing full well that they cannot deliver on their grandiose proposals. They use the suffering of others as a means to gain sympathy, support, and ultimately votes.

This level of manipulation is not only morally reprehensible, but it has dire consequences for our fight against the fentanyl crisis. By turning the issue into a political game, these candidates distract from the real solutions and resources that are needed to address this epidemic. They prioritize their own gain over the lives of our fellow citizens, perpetuating the cycle of suffering.

Another common strategy is the use of misleading statistics and cherry-picked data. These candidates are not interested in presenting a balanced view; instead, they manipulate the information to fuel fear and push their own agendas. They rely on the public’s limited access to accurate information and use it to their advantage.

Along this vein, a common accompanying, manipulative tactic is the creation of false narratives. These candidates twist stories and manipulate events to fit their own narrative, painting themselves as saviors while disregarding the complexities of the crisis. They feed into our desire for a simple solution, offering quick fixes that are unrealistic and ineffective.

These politicians prey on the emotions of the public, appealing to our fear, anger, and sadness. They know that emotions can cloud judgment and lead us to make decisions based on impulse rather than rationality. By tapping into our vulnerabilities, they can manipulate us into supporting their policies and agendas.

These candidates often make grandiose claims about their commitment to combating the fentanyl crisis. They promise to allocate significant resources and implement comprehensive strategies. However, once in office, these promises often vanish into thin air. The urgency and dedication they displayed during their campaigns are conveniently forgotten, leaving us with hollow words and broken promises.

This is nothing more than exploiting the desperation of those affected by the crisis. They know that victims and their families yearn for solutions and are willing to grasp at any glimmer of hope. Taking advantage of this vulnerability, candidates offer hope in the form of rehabilitation programs, enforcement measures, and increased support. Yet, all too often, these promises remain unfulfilled, leaving the victims and their loved ones feeling betrayed and further disillusioned.

Perhaps most disheartening is the lack of accountability. These politicians conveniently shift blame onto others, sidestepping their own responsibility to take decisive action. They create a culture of finger-pointing and excuses, avoiding the necessary conversations and actions that could truly address the fentanyl crisis.

The sad thing about it all is that it makes for good politics and even better campaigning. That is why we can expect to see plenty of it in the coming months.

 

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Joshi is the founding editor of Daily Remedy.

Comments 0

  1. Monty Goddard says:
    2 years ago

    Truth! Disgusting truth!

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

This conversation focuses on debunking myths surrounding GLP-1 medications, particularly the misinformation about their association with pancreatic cancer. The speaker emphasizes the importance of understanding clinical study designs, especially the distinction between observational studies and randomized controlled trials. The discussion highlights the need for patients to critically evaluate the sources of information regarding medication side effects and to empower themselves in their healthcare decisions.

Takeaways
GLP-1 medications are not linked to pancreatic cancer.
Peer-reviewed studies debunk misinformation about GLP-1s.
Anecdotal evidence is not reliable for general conclusions.
Observational studies have limitations in generalizability.
Understanding study design is crucial for evaluating claims.
Symptoms should be discussed in the context of clinical conditions.
Not all side effects reported are relevant to every patient.
Observational studies can provide valuable insights but are context-specific.
Patients should critically assess the relevance of studies to their own experiences.
Engagement in discussions about specific studies can enhance understanding

Chapters
00:00
Debunking GLP-1 Medication Myths
02:56
Understanding Clinical Study Designs
05:54
The Role of Observational Studies in Healthcare
Debunking Myths About GLP-1 Medications
YouTube Video DM9Do_V6_sU
Subscribe

2027 Medicare Advantage & Part D Advance Notice

Clinical Reads

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

by Daily Remedy
February 15, 2026
0

Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The Prevention Gap in Dementia Care

    The Prevention Gap in Dementia Care

    0 shares
    Share 0 Tweet 0
  • Healthcare in Space

    1 shares
    Share 0 Tweet 0
  • Healthcare Natural Rights

    0 shares
    Share 0 Tweet 0
  • Heat Safety Tips Every Pregnant Mother Should Know

    0 shares
    Share 0 Tweet 0
  • What is the 411 on the New 988 Hotline?

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy